Reducing Body Myopathy and Other FHL1-Related Muscular Disorders

Seminars in Pediatric Neurology

Volumn 18, Issue 4, 2011, Pages 257-263

  Schessl, Joachim ^a   Feldkirchner, Sarah ^a   Kubny, Christiana ^a   Schoser, Benedikt ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CREATINE KINASE; FOUR AND A HALF LIM DOMAIN PROTEIN 1; UNCLASSIFIED DRUG;

ANKLE; ARTICLE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FHL1 GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; HEART FUNCTION TEST; HEREDITARY SPINAL MUSCULAR ATROPHY; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JOINT CONTRACTURE; KNEE; LUNG FUNCTION TEST; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; OCCUPATIONAL THERAPY; ONSET AGE; PHENOTYPE; PHYSIOTHERAPY; PROTEIN AGGREGATION; REDUCING BODY MYOPATHY; RESPIRATORY TRACT DISEASE; RIGID SPINE SYNDROME; SLEEP; SOCIAL BEHAVIOR; X LINKED MYOPATHY;

GENETIC DISEASES, X-LINKED; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MALLORY BODIES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; MUTATION; SCOLIOSIS;

EID: 83455263525     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2011.10.007     Document Type: Article

References (56)

1. Curtiss J., Heilig J.S. DeLIMiting development. Bioessays 1998, 20:58-69.
2. Dawid I.B., Toyama R., Taira M. LIM domain proteins. C R Acad Sci III 1995, 318:295-306.
3. Freyd G., Kim S.K., Horvitz H.R. Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature 1990, 344:876-879.
4. Jurata L.W., Gill G.N. Structure and function of LIM domains. Curr Top Microbiol Immunol 1998, 228:75-113.
5. Kadrmas J.L., Beckerle M.C. The LIM domain: From the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 2004, 5:920-931.
6. Brown S., McGrath M.J., Ooms L.M., et al. Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication. J Biol Chem 1999, 274:27083-27091.
7. Johannessen M., Møller S., Hansen T., et al. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 2006, 63:268-284.
8. McGrath M.J., Cottle D.L., Nguyen M.A., et al. Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly. J Biol Chem 2006, 281:7666-7683.
9. Morgan M.J., Madgwick A.J. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle. Biochem Biophys Res Commun 1999, 255:245-250.
10. Fimia G.M., De Cesare D., Sassone-Corsi P. A family of LIM-only transcriptional coactivators: Tissue-specific expression and selective activation of CREB and CREM. Mol Cell Biol 2000, 20:8613-8622.
11. Morgan M.J., Madgwick A.J., Charleston B., et al. The developmental regulation of a novel muscle LIM-protein. Biochem Biophys Res Commun 1995, 212:840-846.
12. Shen Y., Jia Z., Nagele R.G., et al. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res 2006, 66:1543-1552.
13. Morgan M.J., Madgwick A.J. The fourth member of the FHL family of LIM proteins is expressed exclusively in the testis. Biochem Biophys Res Commun 1999, 255:251-255.
14. Lardenois A., Chalmel F., Demougin P., et al. Fhl5/Act, a CREM-binding transcriptional activator required for normal sperm maturation and morphology, is not essential for testicular gene expression. Reprod Biol Endocrinol 2009, 7:133.
15. Cowling B.S., McGrath M.J., Nguyen M.A., et al. Identification of FHL1 as a regulator of skeletal muscle mass: Implications for human myopathy. J Cell Biol 2008, 183:1033-1048.
16. Purcell N.H., Darwis D., Bueno O.F., et al. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 2004, 24:1081-1095.
17. Qin H., Du D., Zhu Y., et al. The PcG protein HPC2 inhibits RBP-J-mediated transcription by interacting with LIM protein KyoT2. FEBS Lett 2005, 579:1220-1226.
18. Qin H., Wang J., Liang Y., et al. RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res 2004, 32:1492-1501.
19. Taniguchi Y., Furukawa T., Tun T., et al. LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol Cell Biol 1998, 18:644-654.
20. Sharma P., Shathasivam T., Ignatchenko V., et al. Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Mol Biosyst 2011, 7:1185-1196.
21. Ng E.K., Lee S.M., Li H.Y., et al. Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1). J Cell Biochem 2001, 82:1-10.
22. Wang J., Qin H., Liang J., et al. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation. J Mol Biol 2007, 370:27-38.
23. Cowling B.S., Cottle D.L., Wilding B.R., et al. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: A comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 2011, 21:237-251.
24. Schessl J., Zou Y., McGrath M.J., et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 2008, 118:904-912.
25. Chen D.H., Raskind W.H., Parson W.W., et al. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: Phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 2010, 296:22-29.
26. Gueneau L., Bertrand A.T., Jais J.P., et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2009, 85:338-353.
27. Quinzii C.M., Vu T.H., Min K.C., et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet 2008, 82:208-213.
28. Schessl J., Columbus A., Hu Y., et al. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: Identification of a second LIM domain mutation in FHL1. Neuropediatrics 2010, 41:43-46.
29. Schessl J., Taratuto A.L., Sewry C., et al. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 2009, 132:452-464.
30. Schoser B., Goebel H.H., Janisch I., et al. Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009, 73:543-551.
31. Shalaby S., Hayashi Y.K., Nonaka I., et al. Novel FHL1 mutations in fatal and benign reducing body myopathy. Neurology 2009, 72:375-376.
32. Windpassinger C., Schoser B., Straub V., et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008, 82:88-99.
33. Knoblauch H., Geier C., Adams S., et al. Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann Neurol 2010, 67:136-140.
34. Shalaby S., Hayashi Y.K., Goto K., et al. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1). Neuromuscul Disord 2008, 18:959-961.
35. Brooke M.H., Neville H.E. Reducing body myopathy. Neurology 1972, 22:829-840.
36. Carpenter S., Karpati G., Holland P. New observations in reducing body myopathy. Neurology 1985, 35:818-827.
37. Dubowitz V. Muscle Disorders in Childhood 1978, WB Saunders, London.
38. Figarella-Branger D., Putzu G.A., Bouvier-Labit C., et al. Adult onset reducing body myopathy. Neuromuscul Disord 1999, 9:580-586.
39. Goebel H.H., Halbig L.E., Goldfarb L., et al. Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: A mixed congenital myopathy. Neuropediatrics 2001, 32:196-205.
40. Hübner G., Pongratz D. Reducing body myopathy-ultrastructure and classification. Virchows Arch A Pathol Anat Histol 1981, 392:97-104. (author's transl).
41. Hübner G., Pongratz D. Granular body myopathy (so-called reducing body myopathy). Pathologe 1982, 3:111-113.
42. Kiyomoto B.H., Murakami N., Kobayashi Y., et al. Fatal reducing body myopathy. Ultrastructural and immunohistochemical observations. J Neurol Sci 1995, 128:58-65.
43. Kobayashi Y., Nihei K., Kuwajima K., et al. Reducing body myopathy-A case report. Rinsho Shinkeigaku 1992, 32:62-67.
44. Nomizu S., Person D.A., Saito C., et al. A unique case of reducing body myopathy. Muscle Nerve 1992, 15:463-466.
45. Oh S.J., Meyers G.J., Wilson E.R., et al. A benign form of reducing body myopathy. Muscle Nerve 1983, 6:278-282.
46. Ohsawa M., Liewluck T., Ogata K., et al. Familial reducing body myopathy. Brain Dev 2007, 29:112-116.
47. Tomé F.M., Fardeau M. Congenital myopathy with "reducing bodies" in muscle fibres. Acta Neuropathol 1975, 31:207-217.
48. Reichmann H., Goebel H.H., Schneider C., et al. Familial mixed congenital myopathy with rigid spine phenotype. Muscle Nerve 1997, 20:411-417.
49. Astrea G., Schessl J., Clement E., et al. Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Disord 2009, 19:689-691.
50. Liewluck T., Hayashi Y.K., Ohsawa M., et al. Unfolded protein response and aggresome formation in hereditary reducing-body myopathy. Muscle Nerve 2007, 35:322-326.
51. Emery A.E. Emery-Dreifuss muscular dystrophy - A 40 year retrospective. Neuromuscul Disord 2000, 10:228-232.
52. Morris G.E., Manilal S. Heart to heart: From nuclear proteins to Emery-Dreifuss muscular dystrophy. Hum Mol Genet 1999, 8:1847-1851.
53. Ellis J.A. Emery-Dreifuss muscular dystrophy at the nuclear envelope: 10 Years on. Cell Mol Life Sci 2006, 63:2702-2709.
54. Zhang Q., Bethmann C., Worth N.F., et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 2007, 16:2816-2833.
55. Pegoraro E., Gavassini B.F., Borsato C., et al. MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord 2007, 17:321-329.
56. Walter M.C., Reilich P., Huebner A., et al. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain 2007, 130:1485-1496.